Dysregulated iron metabolism in polycythemia vera: etiology and consequences
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulated iron metabolism in polycythemia vera: etiology and consequences
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-25
DOI
10.1038/s41375-018-0207-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepcidin agonists as therapeutic tools
- (2018) Carla Casu et al. BLOOD
- Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis
- (2017) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Investigational drugs in phase I and phase II clinical trials for thalassemia
- (2017) Irene Motta et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor
- (2017) Shadi Khalil et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapy
- (2017) Srdan Verstovsek et al. LEUKEMIA RESEARCH
- Iron Deficiency Anemia
- (2017) Thomas G. DeLoughery MEDICAL CLINICS OF NORTH AMERICA
- Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia
- (2016) Gautam Rishi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Minihepcidin peptides as disease modifiers in mice affected by -thalassemia and polycythemia vera
- (2016) C. Casu et al. BLOOD
- JAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis
- (2016) Jean Grisouard et al. BLOOD
- Iron Deficiency Impairs Developing Hippocampal Neuron Gene Expression, Energy Metabolism, and Dendrite Complexity
- (2016) Thomas W. Bastian et al. DEVELOPMENTAL NEUROSCIENCE
- Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy
- (2016) Ruben Mesa et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial
- (2016) S. Verstovsek et al. HAEMATOLOGICA
- Clinical iron deficiency disturbs normal human responses to hypoxia
- (2016) Matthew C. Frise et al. JOURNAL OF CLINICAL INVESTIGATION
- The potential role of hematocrit control on symptom burden among polycythemia vera patients: Insights from the CYTO-PV and MPN-SAF patient cohorts
- (2016) Robyn Marie Scherber et al. LEUKEMIA & LYMPHOMA
- Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial
- (2016) S. Verstovsek et al. HAEMATOLOGICA
- Non-anaemic iron deficiency - a disease looking for recognition of diagnosis: a systematic review
- (2015) Jeremy J. Pratt et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery ofJAK2 V617F
- (2015) Brady L. Stein et al. JOURNAL OF CLINICAL ONCOLOGY
- MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
- (2015) Hans Carl Hasselbalch et al. MEDIATORS OF INFLAMMATION
- Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
- (2015) Alessandro M. Vannucchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart
- (2015) Wenjing Xu et al. Cell Reports
- Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis
- (2014) R. Rampal et al. BLOOD
- Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
- (2014) P. Ponikowski et al. EUROPEAN HEART JOURNAL
- Anemia of Inflammation
- (2014) Elizabeta Nemeth et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Identification of erythroferrone as an erythroid regulator of iron metabolism
- (2014) Léon Kautz et al. NATURE GENETICS
- Deletion of Iron Regulatory Protein 1 Causes Polycythemia and Pulmonary Hypertension in Mice through Translational Derepression of HIF2α
- (2013) Manik C. Ghosh et al. Cell Metabolism
- Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemia
- (2013) Pinar Tarkun et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
- (2013) Gerasimos Filippatos et al. EUROPEAN JOURNAL OF HEART FAILURE
- IL-22 Regulates Iron Availability In Vivo through the Induction of Hepcidin
- (2013) C. L. Smith et al. JOURNAL OF IMMUNOLOGY
- Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors
- (2013) Joseph E. Kiss et al. TRANSFUSION
- JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone
- (2012) A. L. Godfrey et al. BLOOD
- The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice
- (2012) G. Casanovas et al. HAEMATOLOGICA
- Depleted iron stores without anaemia early in pregnancy carries increased risk of lower birthweight even when supplemented daily with moderate iron
- (2012) B. Ribot et al. HUMAN REPRODUCTION
- Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis
- (2012) Qingdu Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
- (2012) Roberto Marchioli et al. NEW ENGLAND JOURNAL OF MEDICINE
- The JAK2 exon 12 mutations: A comprehensive review
- (2011) Linda M. Scott AMERICAN JOURNAL OF HEMATOLOGY
- Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
- (2011) F. Passamonti et al. BLOOD
- Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration
- (2011) P.-A. Krayenbuehl et al. BLOOD
- Low hepcidin accounts for the proinflammatory status associated with iron deficiency
- (2011) A. Pagani et al. BLOOD
- Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis
- (2011) M. Mastrogiannaki et al. HAEMATOLOGICA
- Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes
- (2011) Valeria Santini et al. PLoS One
- Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project
- (2010) A. Piperno et al. BLOOD
- Iron control of erythroid development by a novel aconitase-associated regulatory pathway
- (2010) G. C. Bullock et al. BLOOD
- Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease
- (2010) H. Akada et al. BLOOD
- Detection, evaluation, and management of iron-restricted erythropoiesis
- (2010) L. T. Goodnough et al. BLOOD
- Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter
- (2010) S. Marro et al. HAEMATOLOGICA
- LNKMutations inJAK2Mutation–Negative Erythrocytosis
- (2010) Terra L. Lasho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intestinal Hypoxia-Inducible Transcription Factors Are Essential for Iron Absorption following Iron Deficiency
- (2009) Yatrik M. Shah et al. Cell Metabolism
- Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
- (2009) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Significance of Bone Marrow Biopsy andJAK2V617FMutation in the Differential Diagnosis Between the “Early” Prepolycythemic Phase of Polycythemia Vera and Essential Thrombocythemia
- (2008) Umberto Gianelli et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The Transferrin Receptor Modulates Hfe-Dependent Regulation of Hepcidin Expression
- (2008) Paul J. Schmidt et al. Cell Metabolism
- Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia
- (2008) E. Antonioli et al. HAEMATOLOGICA
- 2-Oxoglutarate-dependent oxygenases control hepcidin gene expression
- (2008) Georgia G. Braliou et al. JOURNAL OF HEPATOLOGY
- Regulation of hepcidin: Insights from biochemical analyses on human serum samples
- (2007) Erwin H.J.M. Kemna et al. BLOOD CELLS MOLECULES AND DISEASES
- Isolated microcytic anemia disclosing a unicentric Castleman disease: The interleukin-6/hepcidin pathway?
- (2007) Stéphane Vinzio et al. European Journal of Internal Medicine
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started